clinical trial simulation tools advancing treatments in rare disease
Published 7 months ago • 93 plays • Length 46:37Download video MP4
Download video MP3
Similar videos
-
22:01
optimization of clinical trial design for rare disease through modeling: example in duchenne’s
-
1:28:54
covid-19 mitigation strategies in pediatric rare disease clinical trials virtual workshop
-
11:08
rare disease endpoint advancement rdea pilot program
-
2:27
jane larkindale - why are c-path drug development tools important in rare disease drug development?
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
2:14:29
rare neurodegenerative disease efforts under the act for als
-
5:27
what is the critical path method (cpm)?
-
42:38
develop project schedule: the critical path method
-
12:38
clinical trial simulation
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
1:29:03
2021 pro consortium workshop: identifying coas for use in rare disease treatment trials
-
2:06
rare disease patient voice: kelly barendt
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
1:59
jane larkindale - what is c-path doing that is unique in drug development for rare disease?
-
1:51
rare disease patient voice: justin moy
-
57:06
the role of integrated datasets in addressing rare diseases research challenges
-
2:33
rare disease patient voice: david fajgenbaum
-
1:00:10
guids and de-identification tools for rare diseases
-
58:49
webinar: how rdca-dap can help inform optimal trial design in progressive rare disease
-
57:07
what you need to know about the rare disease cures accelerator-data and analytics platform
-
24:22
2022 rdca-dap workshop: case study 3, duchenne regulatory science consortia (d-rsc)